ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2227

Worrisome Mortality Trends over 20 Years Among Patients with Underlying Ischemic Heart Disease and Rheumatoid Arthritis

Yukthi Mudiam1 and Shreyas Singireddy2, 1Apollo Institute of Medical Sciences and Research, Richmond, TX, 2Department of Cardiology, University of Illinois College of Medicine, Peoria, IL

Meeting: ACR Convergence 2024

Keywords: Heart disease, Mortality, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: RA – Diagnosis, Manifestations, & Outcomes Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Ischemic heart disease (IHD) is one of the leading causes of death in the United States. Rheumatoid arthritis (RA), a chronic inflammatory condition affecting multiple joints, is associated with an increased risk of developing IHD. Both the diseases have been shown to independently affect mortality rates in adults in a significant way. The purpose of this study was to assess the trends in mortality from IHD and underlying seropositive RA among adults of all ages in the United States.

Methods: This study used records from the CDC WONDER (Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research) database, which were analyzed from 1999-2020 for IHD and seropositive RA-related mortality in adults. Age-adjusted mortality rates (AAMRs) per 100,000 persons were calculated and stratified by sex, race/ethnicity, and geographic region.

Results: A total of 9,103,610 deaths were identified over the past 20 years in patients with IHD and seropositive RA. Males were more affected than females with higher AAMR of 205.6 (205.4-205.8, CI 95%) versus 118.6 (118.4-118.7, CI 95%). Regarding race, Blacks had the highest AAMR of 180.1 (179.7-180.5, CI 95%), followed by Whites (157), American Indians (108.3) and then Asians (85.2). Region wise, the highest AAMR was seen in the Northeast (169.2; 168.9-169.4, CI 95%), followed by the Midwest (158.7), South (158) and finally the West (139.2).

Conclusion: Males were significantly more affected than females. Blacks were disproportionately affected, and those residing in the Northeast region of the United States were affected more. Targeted strategies are needed to curb the elevated mortality rates seen among males and black individuals.


Disclosures: Y. Mudiam: None; S. Singireddy: None.

To cite this abstract in AMA style:

Mudiam Y, Singireddy S. Worrisome Mortality Trends over 20 Years Among Patients with Underlying Ischemic Heart Disease and Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/worrisome-mortality-trends-over-20-years-among-patients-with-underlying-ischemic-heart-disease-and-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/worrisome-mortality-trends-over-20-years-among-patients-with-underlying-ischemic-heart-disease-and-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology